MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

PHENOTYPIC DESCRIPTION OF TWO UNREPORTED FAMILIES WITH ANO3 DYSTONIA

A. Trinchillo, G. de Joanna, M. Esposito (Naples, Italy)

Meeting: 2022 International Congress

Abstract Number: 568

Keywords: Botulinum toxin: Clinical applications: dystonia, Deep brain stimulation (DBS), Dystonia: Genetics

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: This is the phenotypic description of two families affected by hereditary dystonia associated to gene ANO3 mutation (DYT24), one with a heterozygous verisimilarly pathogenic variant (hVPV), and the other with a heterozygous variant of uncertain meaning (hVUM).

Background: ANO3 gene encodes for a Ca2þ-gated chloride channel. DYT24 has an adult onset and usually presents with cranio-cervical dystonia combined with tremor.

Method: Phenomenology description (with related videos), next generation sequencing of dystonia genetic panel, multichannel EMG were performed in both families.

Results: In one family, proband was the mother, who presented a severe axial dystonia associated with tremor at the head and upper limbs, whereas her son had a cranio-cervical dystonia and head jerky movements. Genetic analysis identified a hVPV in ANO3 gene. At NGS a PINK1 gene hVUM was found in the proband and the son displayed in addition of the ANO3 mutation a heterozygous mutation in PANK2 gene. Both patients are under deep brain stimulation of internal globus pallidus from 12 years with benefits that were more evident during the first five years after the operation. In the other family, proband is a 60 y.o. man who presented cranial dystonia (Meige-type) and upper limbs dystonic tremor, whereas his sister shows just dystonic features of Meige syndrome. The ANO3 mutation identified in the proband was a hVUM and, genetic analysis is still ongoing for the sister. Molecular confirm of the same mutation of ANO3 in the sister would suggest the identification of a new mutation. In both families the electrophysiological assessment was consistent with a jerky tremor of the head (family 1), and of the arm (family 2), recordings were not suggestive of myoclonus. All patients are under treatment with botulinum toxin with benefits. They all reported dystonia onset before the age of 20 year. Brain MRI scan showed normal findings in all of them.

Conclusion: DYT24 has heterogeneous clinical aspects, both families here reported have cranio-cervical and upper limb impairment but with different clinical presentation. Patients of the same family are similar but show significant differences with subjects of the other family.

References: Albanese, A., Bhatia, K., Bressman, S. B., Delong, M. R., Fahn, S., Fung, V. S. C., Hallett, M., Jankovic, J., Jinnah, H. A., Klein, C., Lang, A. E., Mink, J. W., & Teller, J. K. (2013). Phenomenology and classification of dystonia: A consensus update. In Movement Disorders (Vol. 28, Issue 7, pp. 863–873). https://doi.org/10.1002/mds.25475
Blackburn, P. R., Zimmermann, M. T., Gass, J. M., Harris, K. G., Cousin, M. A., Boczek, N. J., Ross, O. A., Klee, E. W., Brazis, P. W., van Gerpen, J. A., & Atwal, P. S. (2016). A novel ANO3 variant identified in a 53-year-old woman presenting with hyperkinetic dysarthria, blepharospasm, hyperkinesias, and complex motor tics. BMC Medical Genetics, 17(1). https://doi.org/10.1186/s12881-016-0354-7
Charlesworth, G., Plagnol, V., Holmström, K. M., Bras, J., Sheerin, U. M., Preza, E., Rubio-Agusti, I., Ryten, M., Schneider, S. A., Stamelou, M., Trabzuni, D., Abramov, A. Y., Bhatia, K. P., & Wood, N. W. (2012). Mutations in ANO3 cause dominant craniocervical dystonia: Ion channel implicated in pathogenesis. American Journal of Human Genetics, 91(6), 1041–1050. https://doi.org/10.1016/j.ajhg.2012.10.024
Fahn, S. (2011). Classification of movement disorders. In Movement Disorders (Vol. 26, Issue 6, pp. 947–957). https://doi.org/10.1002/mds.23759
Jinnah, H. A., & Sun, Y. v. (2019). Dystonia genes and their biological pathways. In Neurobiology of Disease (Vol. 129, pp. 159–168). Academic Press Inc. https://doi.org/10.1016/j.nbd.2019.05.014
Kuo, M. C., Lin, H. I., & Lin, C. H. (2019). Craniocervical dystonia with levodopa-responsive parkinsonism co-segregating with a pathogenic ANO3 mutation in a Taiwanese family. In Parkinsonism and Related Disorders (Vol. 62, pp. 236–238). Elsevier Ltd. https://doi.org/10.1016/j.parkreldis.2019.01.020
Lasky, L., Bliss, L., & Sidiropoulos, C. (2019). Successful Pallidal Deep Brain Stimulation Treatment in a Case of Generalized Dystonia due to a Novel ANO3 Mutation . Case Reports in Neurological Medicine, 2019, 1–2. https://doi.org/10.1155/2019/3154653
Laurencin, C., Broussolle, E., Danaila, T., Anheim, M., Chelly, J., & Thobois, S. (2019). A novel heterozygous ANO3 mutation responsible for myoclonic dystonia. In Journal of the Neurological Sciences (Vol. 403, pp. 65–66). Elsevier B.V. https://doi.org/10.1016/j.jns.2019.06.014
Li, S., Wang, L., Yang, Y., Ma, J., & Wan, X. (2020). ANO3 Mutations in Chinese Dystonia: A Genetic Screening Study Using Next-Generation Sequencing. Frontiers in Neurology, 10. https://doi.org/10.3389/fneur.2019.01351
Münchau, A., Valente, E. M., Davis, M. B., Stinton, V., Wood, N. W., Quinn, N. P., & Bhatia, K. P. (2000). A Yorkshire Family With Adult-Onset Cranio-Cervical Primary Torsion Dystonia. http://www.marshmed.org/
Olschewski, L., Jesús, S., Kim, H. J., Tunc, S., Löns, S., Junker, J., Zeuner, K. E., Kühn, A. A., Kuhlenbäumer, G., Schäffer, E., Berg, D., Kasten, M., Ferbert, A., Altenmüller, E., Brüggemann, N., Bauer, P., Rolfs, A., Jeon, B., Bäumer, T., … Lohmann, K. (2019). Role of ANO3 mutations in dystonia: A large-scale mutational screening study. Parkinsonism and Related Disorders, 62, 196–200. https://doi.org/10.1016/j.parkreldis.2018.12.030
Shibasaki, H., & Hallett, M. (2005). Electrophysiological studies of myoclonus. Muscle and Nerve, 31(2), 157–174. https://doi.org/10.1002/mus.20234
Stamelou, M., Charlesworth, G., Cordivari, C., Schneider, S. A., Kägi, G., Sheerin, U. M., Rubio-Agusti, I., Batla, A., Houlden, H., Wood, N. W., & Bhatia, K. P. (2014a). The phenotypic spectrum of DYT24 due to ANO3 mutations. Movement Disorders, 29(7), 928–934. https://doi.org/10.1002/mds.25802
Stamelou, M., Charlesworth, G., Cordivari, C., Schneider, S. A., Kägi, G., Sheerin, U. M., Rubio-Agusti, I., Batla, A., Houlden, H., Wood, N. W., & Bhatia, K. P. (2014b). The phenotypic spectrum of DYT24 due to ANO3 mutations. Movement Disorders, 29(7), 928–934. https://doi.org/10.1002/mds.25802
Yoo, D., Kim, H.-J., Chae, J.-H., Paek, S. H., & Jeon, B. (2019). Successful Pallidal Deep Brain Stimulation in a Patient with Childhood-Onset Generalized Dystonia with ANO3 Mutation. Journal of Movement Disorders, 12(3), 190–191. https://doi.org/10.14802/jmd.19016
Zech, M., Boesch, S., Jochim, A., Weber, S., Meindl, T., Schormair, B., Wieland, T., Lunetta, C., Sansone, V., Messner, M., Mueller, J., Ceballos-Baumann, A., Strom, T. M., Colombo, R., Poewe, W., Haslinger, B., & Winkelmann, J. (2017). Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up. Movement Disorders, 32(4), 549–559. https://doi.org/10.1002/mds.26808

To cite this abstract in AMA style:

A. Trinchillo, G. de Joanna, M. Esposito. PHENOTYPIC DESCRIPTION OF TWO UNREPORTED FAMILIES WITH ANO3 DYSTONIA [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/phenotypic-description-of-two-unreported-families-with-ano3-dystonia/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/phenotypic-description-of-two-unreported-families-with-ano3-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley